The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.

Condition	Treatment or Intervention	Phase
Cocaine-Related Disorders	Drug: Piracetam	Phase I

Further Study Details: 

Ages Eligible for Study:  21 Years   -   45 Years,  Genders Eligible for Study:  Male

Criteria

Please contact site for information.

Pennsylvania
      University of Pennsylvania, Philadelphia,  Pennsylvania,  19104 6178,  United States

Study chairs or principal investigators

Kyle Kampman, M.D.,  Principal Investigator,  University of Pennsylvania   

Study ID Numbers:  NIDA-00238-3; K02-00238-3
Record last reviewed:  October 1996
Last Updated:  November 18, 2004
Record first received:  September 20, 1999
ClinicalTrials.gov Identifier:  NCT00000198
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08